Is IBM A Buy or A Bye?
πππThe market is reeling from a historic tech earthquake. On Tuesday $IBM(IBM)$
The source of the carnage? An unusually candid concession from CEO Arvind Krishna. In a preliminary Q2 warning, Krishna admitted the firm faltered, missing revenue expectations by only achieving a measly 1% growth of USD 17.2 billion vs the USD 17.85 billion expected. The infrastructure division plummeted 7% and software growth slowed down to 5%.
Why the Market Panicked?
Budget Cannibalisation: Corporate clients did not stop spending on technology. They pivoted. This is a prime example of AI Cannibalisation where companies slash their budgets for normal tech products just to buy trendy AI tools instead.
The Grocery Analogy: Think of a corporate budget like a household grocery bill. To afford expensive organic steak (AI hardware and chips), enterprises stopped buying everyday staples like bread and milk (IBM's traditional software and mainframes). They redirected their capital expenditure to buy raw AI infrastructure from hardware competitors.
The Mythos Freeze: The imminent launch of Anthropic's Mythos AI model completely paralysed enterprise cybersecurity pipelines. Clients froze multi million dollar software deals with IBM to reassess how this new security vulnerability tool would impact their operations.
The Systemic Threat: This isn't just an IBM issue. It is a canary in the tech coal mine. The sudden budget shift dragged down SaaS giants like Microsoft, Salesforce and Service Now. This exposes a terrifying truth: AI infrastructure is eating traditional software alive.
The Silver Lining: IBM's hidden saving graces
Despite the carnage, IBM is far from dead. Long term investors point to crucial structural advantages that could fuel a future turnaround.
The Massive AI Backlog: While current software sales slowed, IBM's actual generative AI book of business remains an incredible bright spot, scaling past a robust USD 3 billion USD pipeline.
The Consulting Lifeline: IBM owns a massive global consulting wing. When companies finish panic buying raw AI hardware from other vendors, they will need IBM's consultants to step in and safely integrate those complex systems into legacy business pipelines.
A Defensive Dividend Base: For income seekers, IBM boasts a resilient 4% dividend yield backed by a 30 year track record of consistent increases. This strong cash flow history creates a natural psychological safety net for its stock price.
2 SaaS stocks exceptions to hold in your portfolio
$Salesforce.com(CRM)$
$ServiceNow(NOW)$
Investors Playbook: What You Should Do Now
Audit Software Exposure: Review your portfolio and look for traditional SaaS companies that make money purely by charging per user seat licences without an AI monetisation model.
Follow the Capital Flow: Shift a portion of your capital toward the clear infrastructure winners - companies making semiconductors, advanced cloud computing architecture and specialised data center hardware.
Screen for AI native Software: Only invest in software companies like Salesforce or ServiceNow that can prove they are successfully charging premium usage based consumption fees for core proprietary AI integration.
Concluding Thoughts
The Verdict: IBM remains a definitive Bye, not a Buy for short term traders but long term value hunters should keep it on their radar.
While a potential 37% upside is predicted by analysts, IBM has become a classic value trap. It is a stock that looks cheap on the surface but whose current revenue is actively being eaten alive or cannibalised by the AI boom.
Until Big Blue proves that its consulting arm can cash in on the AI Gold Rush, it is best to stay on the sidelines.
@Tiger_comments @Tiger_SG @TigerStars
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
